Shawn F. Johnson

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera et al. · Nature · 2017 · 540 citations · Full text

Breast Oncology, Medicine, Immunology +9

Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer

Jian Hu, Soyoon Hwang, Marc Liesa et al. · Cell · 2012 · 286 citations · Full text

Medicine, Pathology, Cancer Biology +7

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 279 citations · Full text

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

Yifan Wang, Andrea J. Bernhardy, Cristina Cruz et al. · Cancer Research · 2016 · 267 citations · Full text

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance

Neil Johnson, Shawn F. Johnson, Wei Yao et al. · Proceedings of the National Academy of Sciences · 2013 · 261 citations · Full text